JAPANESE refrigerated van brand Cooltech said the outlook for the Philippine cold chain industry remains strong due to growing demand from food and pharmaceuticalsJAPANESE refrigerated van brand Cooltech said the outlook for the Philippine cold chain industry remains strong due to growing demand from food and pharmaceuticals

Refrigerated van maker sees growth in PHL driven by food, pharma industries

2025/12/21 20:40
2 min read
For feedback or concerns regarding this content, please contact us at [email protected]

JAPANESE refrigerated van brand Cooltech said the outlook for the Philippine cold chain industry remains strong due to growing demand from food and pharmaceuticals producers.

“Cooltech is optimistic about its long-term outlook in the Philippine market, driven by the country’s growing demand for reliable cold chain logistics, expanding food and pharmaceutical sectors, and increasing awareness of quality transport solutions,” according to Centro Nippon Fruehauf Cooltech, Inc. (CFCI), which distributes Cooltech products.

CFCI General Manager Benigno V. Dumlao, Jr. said more companies now recognize the importance of maintaining product quality from origin to destination.

“The Philippines is experiencing steady growth in industries that depend heavily on cold chain reliability — food distribution, dairy, pharmaceuticals, and retail,” he said.

“We see a clear shift toward professional-grade refrigerated transport, and that aligns perfectly with what Cooltech offers,” he added.

The company recently participated in the VDS Golf Tournament, where it showcased its flagship Fuso F-resh Refrigerated Van.

“The strong interest generated by the Fuso F-resh Van during the tournament reflects this trend… The vehicle attracted logistics professionals, entrepreneurs, and executives who were keen to learn more about its advanced cooling technology, durable build quality, and seamless integration with the trusted Fuso commercial vehicle platform,” the company said.

“These interactions provided valuable insights into customer needs and reaffirmed Cooltech’s confidence in the market,” it added.

Meanwhile, Mr. Dumlao said that the company plans to expand its footprint by supporting businesses of varying sizes.

“We believe the next phase of growth will come from helping more Filipino enterprises professionalize their cold chain operations,” he said.

“As demand rises, so does the need for solutions that are efficient, compliant, and built to last,” he added.

“The outlook for Cooltech in the Philippines is very positive. We are committed to growing with the market and supporting industries that keep the country moving — fresh, safe, and efficient,” he said. — Justine Irish D. Tabile

Market Opportunity
PHILCOIN Logo
PHILCOIN Price(PHL)
$0.02253
$0.02253$0.02253
-3.47%
USD
PHILCOIN (PHL) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Key Takeaways Vitalik Buterin wants Ethereum apps built to survive without developers, corporate servers, or trusted third parties Two major […] The post Vitalik
Share
Coindoo2026/03/07 15:49
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

The post Short-term profit-taking pushes Bitcoin back below key $70K level – What next? appeared on BitcoinEthereumNews.com. Bitcoin [BTC] rallied as high as $74
Share
BitcoinEthereumNews2026/03/07 16:09